 Catherine Flaitz
Concepts (789)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 58 | 2017 | 155 | 4.510 |
Why?
| | Mouth Diseases | 21 | 2018 | 45 | 2.950 |
Why?
| | Mouth Neoplasms | 23 | 2012 | 120 | 2.120 |
Why?
| | Cariostatic Agents | 23 | 2014 | 30 | 2.070 |
Why?
| | Diagnosis, Differential | 60 | 2014 | 1481 | 1.960 |
Why?
| | Fluorides | 23 | 2014 | 49 | 1.860 |
Why?
| | Gingival Diseases | 12 | 2012 | 20 | 1.720 |
Why?
| | Dental Enamel | 32 | 2007 | 70 | 1.630 |
Why?
| | Mouth Mucosa | 21 | 2014 | 92 | 1.350 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 27 | 1.330 |
Why?
| | Dental Restoration, Permanent | 12 | 2003 | 43 | 1.240 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 25 | 1.080 |
Why?
| | Precancerous Conditions | 6 | 2013 | 169 | 0.990 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 127 | 0.960 |
Why?
| | Tooth, Deciduous | 12 | 2006 | 18 | 0.910 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.910 |
Why?
| | Lip Diseases | 6 | 2013 | 7 | 0.900 |
Why?
| | Carcinoma, Squamous Cell | 11 | 2013 | 683 | 0.880 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.880 |
Why?
| | Molar | 22 | 2014 | 49 | 0.860 |
Why?
| | Pit and Fissure Sealants | 10 | 2007 | 19 | 0.860 |
Why?
| | Mandibular Diseases | 7 | 2007 | 12 | 0.860 |
Why?
| | Lichen Planus, Oral | 4 | 2013 | 5 | 0.860 |
Why?
| | HIV Infections | 31 | 2013 | 2828 | 0.710 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.690 |
Why?
| | Humans | 228 | 2018 | 136764 | 0.670 |
Why?
| | Gingiva | 4 | 2012 | 25 | 0.650 |
Why?
| | Condylomata Acuminata | 3 | 2013 | 7 | 0.630 |
Why?
| | Composite Resins | 10 | 2010 | 110 | 0.600 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.590 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.560 |
Why?
| | Burns, Chemical | 2 | 2012 | 32 | 0.540 |
Why?
| | Fluorides, Topical | 9 | 2004 | 13 | 0.540 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 81 | 0.520 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 21 | 0.490 |
Why?
| | Resin Cements | 8 | 2010 | 28 | 0.490 |
Why?
| | Tongue | 7 | 2004 | 81 | 0.480 |
Why?
| | Candidiasis, Oral | 13 | 2007 | 18 | 0.480 |
Why?
| | Saliva | 8 | 2003 | 242 | 0.470 |
Why?
| | Male | 93 | 2017 | 67309 | 0.460 |
Why?
| | Laser Therapy | 12 | 2006 | 130 | 0.460 |
Why?
| | Maxillary Diseases | 4 | 2012 | 8 | 0.450 |
Why?
| | Radiography | 19 | 2007 | 822 | 0.450 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.450 |
Why?
| | Child | 56 | 2018 | 21822 | 0.440 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.440 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.440 |
Why?
| | Dental Bonding | 6 | 2010 | 33 | 0.440 |
Why?
| | Analysis of Variance | 24 | 2007 | 1316 | 0.430 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.430 |
Why?
| | Mouth Floor | 4 | 2001 | 7 | 0.420 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 166 | 0.420 |
Why?
| | Dental Plaque | 6 | 2004 | 18 | 0.420 |
Why?
| | Microscopy, Polarization | 17 | 2013 | 31 | 0.410 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 7 | 0.400 |
Why?
| | Lasers | 7 | 2004 | 130 | 0.400 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 16 | 0.400 |
Why?
| | Oral Ulcer | 8 | 2003 | 10 | 0.390 |
Why?
| | Glass Ionomer Cements | 6 | 2003 | 10 | 0.390 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 41 | 0.390 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.380 |
Why?
| | Dentifrices | 3 | 2014 | 5 | 0.380 |
Why?
| | Purpura | 1 | 2012 | 17 | 0.380 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.380 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.370 |
Why?
| | Jaw Diseases | 2 | 2005 | 4 | 0.360 |
Why?
| | Gingivitis | 2 | 2010 | 12 | 0.360 |
Why?
| | Head and Neck Neoplasms | 4 | 2002 | 604 | 0.360 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.360 |
Why?
| | Palatal Neoplasms | 2 | 2001 | 7 | 0.350 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.350 |
Why?
| | Child, Preschool | 32 | 2017 | 11000 | 0.340 |
Why?
| | Cheek | 2 | 2000 | 17 | 0.340 |
Why?
| | Dental Cavity Preparation | 7 | 2003 | 8 | 0.340 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.340 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.340 |
Why?
| | HIV Seropositivity | 4 | 2007 | 125 | 0.330 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.330 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.330 |
Why?
| | Tooth Eruption | 5 | 2014 | 10 | 0.330 |
Why?
| | Female | 75 | 2017 | 72787 | 0.330 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 16 | 0.320 |
Why?
| | Schools, Dental | 2 | 2011 | 14 | 0.320 |
Why?
| | Leukoplakia, Oral | 3 | 2011 | 11 | 0.320 |
Why?
| | Palatine Tonsil | 1 | 2009 | 48 | 0.320 |
Why?
| | Teaching | 1 | 2011 | 224 | 0.310 |
Why?
| | Cysts | 3 | 2002 | 111 | 0.300 |
Why?
| | Adult | 55 | 2013 | 37630 | 0.300 |
Why?
| | Academic Medical Centers | 2 | 2011 | 504 | 0.300 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.300 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 22 | 0.290 |
Why?
| | Immunocompromised Host | 6 | 2013 | 202 | 0.290 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 8 | 0.290 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.290 |
Why?
| | Epithelium | 9 | 2012 | 311 | 0.290 |
Why?
| | Acyclovir | 6 | 2004 | 101 | 0.280 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.280 |
Why?
| | Histiocytosis, Langerhans-Cell | 2 | 2005 | 37 | 0.280 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 10 | 0.280 |
Why?
| | Dental Materials | 3 | 2003 | 57 | 0.280 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.280 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 230 | 0.280 |
Why?
| | Acid Etching, Dental | 7 | 2001 | 15 | 0.270 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2011 | 327 | 0.270 |
Why?
| | Incisor | 4 | 2002 | 18 | 0.270 |
Why?
| | Learning | 1 | 2011 | 406 | 0.270 |
Why?
| | Middle Aged | 41 | 2013 | 33228 | 0.270 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.270 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 2 | 0.270 |
Why?
| | Zirconium | 3 | 2001 | 8 | 0.270 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 6 | 0.270 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 9 | 0.270 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 324 | 0.260 |
Why?
| | Dental Implants | 1 | 2007 | 11 | 0.260 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.260 |
Why?
| | Saliva, Artificial | 9 | 2014 | 11 | 0.260 |
Why?
| | Valine | 5 | 2004 | 82 | 0.260 |
Why?
| | Dentists | 3 | 2001 | 20 | 0.260 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.260 |
Why?
| | Tooth, Impacted | 3 | 2003 | 8 | 0.250 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.250 |
Why?
| | Biopsy | 8 | 2012 | 1124 | 0.250 |
Why?
| | Texas | 8 | 2017 | 243 | 0.250 |
Why?
| | Maxilla | 7 | 2002 | 37 | 0.250 |
Why?
| | Silicon Dioxide | 3 | 2001 | 114 | 0.240 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 98 | 0.240 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 3 | 0.240 |
Why?
| | Sarcoidosis | 1 | 2007 | 159 | 0.240 |
Why?
| | Dental Caries Susceptibility | 11 | 2006 | 11 | 0.240 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 7 | 0.240 |
Why?
| | Dental Research | 1 | 2005 | 5 | 0.240 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.230 |
Why?
| | Cytodiagnosis | 4 | 2012 | 33 | 0.230 |
Why?
| | Cuspid | 2 | 2002 | 11 | 0.230 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 6 | 0.230 |
Why?
| | Blister | 2 | 2001 | 41 | 0.230 |
Why?
| | Tooth Root | 9 | 2013 | 14 | 0.230 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 200 | 0.230 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.230 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.230 |
Why?
| | Tongue Diseases | 1 | 2004 | 9 | 0.220 |
Why?
| | Mucocele | 2 | 2001 | 12 | 0.220 |
Why?
| | Hemangioma | 2 | 2002 | 48 | 0.220 |
Why?
| | Calcium Phosphates | 2 | 2004 | 26 | 0.220 |
Why?
| | Warts | 2 | 2001 | 6 | 0.220 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.220 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 14 | 0.210 |
Why?
| | Calcium | 5 | 2007 | 1197 | 0.210 |
Why?
| | Argon | 16 | 2004 | 21 | 0.210 |
Why?
| | Hyperplasia | 5 | 2003 | 175 | 0.210 |
Why?
| | Lymphatic Diseases | 2 | 2002 | 22 | 0.210 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.210 |
Why?
| | Erythema | 2 | 2001 | 29 | 0.210 |
Why?
| | Prognosis | 12 | 2002 | 4013 | 0.200 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 192 | 0.200 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.200 |
Why?
| | Dental Amalgam | 1 | 2002 | 3 | 0.200 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 2002 | 6 | 0.200 |
Why?
| | Adolescent | 30 | 2014 | 21382 | 0.190 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.190 |
Why?
| | Lip Neoplasms | 1 | 2002 | 2 | 0.190 |
Why?
| | Germinal Center | 1 | 2002 | 58 | 0.190 |
Why?
| | Universities | 1 | 2005 | 433 | 0.190 |
Why?
| | Crowns | 1 | 2002 | 4 | 0.190 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.190 |
Why?
| | Toothpastes | 2 | 2000 | 5 | 0.190 |
Why?
| | Personal Autonomy | 2 | 2013 | 49 | 0.190 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.190 |
Why?
| | Disease Progression | 6 | 2013 | 2750 | 0.190 |
Why?
| | Sialadenitis | 1 | 2001 | 2 | 0.190 |
Why?
| | Cyclosporine | 1 | 2003 | 268 | 0.180 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 11 | 0.180 |
Why?
| | Nevus, Blue | 1 | 2001 | 2 | 0.180 |
Why?
| | Diazepam | 3 | 1986 | 35 | 0.180 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 6 | 0.180 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 72 | 0.180 |
Why?
| | Light | 6 | 2012 | 378 | 0.180 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 271 | 0.180 |
Why?
| | Fibroma | 1 | 2001 | 21 | 0.180 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 13 | 0.180 |
Why?
| | Durapatite | 2 | 2004 | 37 | 0.180 |
Why?
| | Hair Dyes | 1 | 2000 | 2 | 0.170 |
Why?
| | Lip | 2 | 2000 | 23 | 0.170 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 60 | 0.170 |
Why?
| | Dental Care for Children | 2 | 1999 | 10 | 0.170 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 54 | 0.170 |
Why?
| | Candida | 4 | 2006 | 37 | 0.170 |
Why?
| | Neuroma | 1 | 2000 | 5 | 0.170 |
Why?
| | Malpractice | 1 | 2001 | 45 | 0.170 |
Why?
| | Resins, Synthetic | 1 | 2000 | 14 | 0.170 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2001 | 92 | 0.170 |
Why?
| | Palate, Hard | 1 | 2000 | 6 | 0.170 |
Why?
| | Sunlight | 1 | 2001 | 73 | 0.170 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 889 | 0.170 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 116 | 0.170 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.170 |
Why?
| | Lymphangioma | 1 | 2000 | 7 | 0.170 |
Why?
| | Calcinosis | 1 | 2002 | 235 | 0.170 |
Why?
| | Lipoma | 1 | 2000 | 16 | 0.160 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 49 | 0.160 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2011 | 1058 | 0.160 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 65 | 0.160 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.160 |
Why?
| | Virus Replication | 6 | 2007 | 480 | 0.160 |
Why?
| | Child Behavior | 3 | 2014 | 246 | 0.160 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1272 | 0.160 |
Why?
| | Mandible | 5 | 2007 | 78 | 0.160 |
Why?
| | Candidiasis | 1 | 1999 | 56 | 0.150 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 560 | 0.150 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 129 | 0.150 |
Why?
| | Vinblastine | 3 | 1995 | 70 | 0.150 |
Why?
| | Attitude to Health | 2 | 2013 | 437 | 0.150 |
Why?
| | Surface Properties | 8 | 2003 | 412 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 183 | 0.150 |
Why?
| | Facial Dermatoses | 3 | 2008 | 16 | 0.150 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 431 | 0.150 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.150 |
Why?
| | Recurrence | 6 | 2003 | 1055 | 0.140 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 6 | 0.140 |
Why?
| | Nose Diseases | 1 | 1998 | 13 | 0.140 |
Why?
| | Pulpotomy | 2 | 1989 | 3 | 0.140 |
Why?
| | Myxoma | 1 | 1997 | 12 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1462 | 0.140 |
Why?
| | Palate | 1 | 1998 | 38 | 0.140 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.140 |
Why?
| | Periodontal Diseases | 3 | 2007 | 60 | 0.130 |
Why?
| | Cleft Lip | 1 | 2017 | 51 | 0.130 |
Why?
| | Specimen Handling | 1 | 1998 | 181 | 0.130 |
Why?
| | Bicuspid | 5 | 2001 | 17 | 0.130 |
Why?
| | Dentin-Bonding Agents | 4 | 2003 | 17 | 0.130 |
Why?
| | Taste Buds | 1 | 1999 | 208 | 0.130 |
Why?
| | Cleft Palate | 1 | 2017 | 67 | 0.130 |
Why?
| | Xylitol | 2 | 2014 | 4 | 0.130 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.130 |
Why?
| | Peroxides | 1 | 1996 | 19 | 0.130 |
Why?
| | Cooperative Behavior | 4 | 2011 | 445 | 0.130 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.130 |
Why?
| | Secondary Prevention | 3 | 2002 | 232 | 0.130 |
Why?
| | Acids | 2 | 2012 | 18 | 0.130 |
Why?
| | Chronic Disease | 2 | 2018 | 1784 | 0.130 |
Why?
| | Melanoma | 2 | 2000 | 757 | 0.120 |
Why?
| | Ulcer | 1 | 1996 | 32 | 0.120 |
Why?
| | Urea | 1 | 1996 | 81 | 0.120 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.120 |
Why?
| | Langerhans Cells | 2 | 2007 | 12 | 0.120 |
Why?
| | HIV Seronegativity | 4 | 2007 | 28 | 0.120 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 3 | 0.120 |
Why?
| | Acculturation | 1 | 2016 | 53 | 0.120 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 6 | 0.120 |
Why?
| | Statistics as Topic | 5 | 2001 | 307 | 0.120 |
Why?
| | Osteomyelitis | 2 | 2000 | 131 | 0.120 |
Why?
| | Infant | 11 | 2002 | 9398 | 0.120 |
Why?
| | Age Factors | 6 | 2016 | 3284 | 0.120 |
Why?
| | Sex Factors | 4 | 2016 | 2060 | 0.120 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 15 | 0.110 |
Why?
| | Phosphates | 4 | 2013 | 182 | 0.110 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.110 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 1 | 0.110 |
Why?
| | Hernia | 1 | 2014 | 11 | 0.110 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.110 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 54 | 0.110 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 190 | 0.110 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.110 |
Why?
| | Fat Necrosis | 1 | 1993 | 9 | 0.110 |
Why?
| | Tooth Abnormalities | 2 | 2001 | 13 | 0.110 |
Why?
| | Risk Factors | 10 | 2018 | 10326 | 0.110 |
Why?
| | Hypercalcemia | 1 | 1993 | 19 | 0.110 |
Why?
| | Conscious Sedation | 1 | 2014 | 91 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2001 | 852 | 0.100 |
Why?
| | Epithelial Cells | 4 | 2007 | 1094 | 0.100 |
Why?
| | Papillomaviridae | 3 | 2000 | 126 | 0.100 |
Why?
| | Aurothioglucose | 1 | 1993 | 7 | 0.100 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.100 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 155 | 0.100 |
Why?
| | Thermodynamics | 5 | 2001 | 401 | 0.100 |
Why?
| | Keratosis | 2 | 2003 | 16 | 0.100 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 35 | 0.100 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 3 | 0.100 |
Why?
| | Mass Screening | 2 | 2012 | 1267 | 0.100 |
Why?
| | Antiviral Agents | 6 | 2004 | 739 | 0.100 |
Why?
| | Acrylic Resins | 3 | 2007 | 46 | 0.100 |
Why?
| | DMF Index | 5 | 2003 | 17 | 0.100 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 198 | 0.100 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.100 |
Why?
| | Candy | 1 | 2012 | 5 | 0.090 |
Why?
| | Curriculum | 2 | 2011 | 976 | 0.090 |
Why?
| | Wound Healing | 2 | 2005 | 328 | 0.090 |
Why?
| | Dentin | 5 | 2001 | 24 | 0.090 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.090 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 8 | 0.090 |
Why?
| | Simplexvirus | 3 | 1998 | 80 | 0.090 |
Why?
| | Adolescent Behavior | 2 | 2002 | 529 | 0.090 |
Why?
| | Dental Hygienists | 1 | 2011 | 11 | 0.090 |
Why?
| | Administrative Personnel | 1 | 2011 | 29 | 0.090 |
Why?
| | Keratins | 1 | 2012 | 173 | 0.090 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 73 | 0.090 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.090 |
Why?
| | General Practice, Dental | 3 | 2006 | 5 | 0.090 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.090 |
Why?
| | Staff Development | 1 | 2011 | 56 | 0.090 |
Why?
| | Truth Disclosure | 1 | 2011 | 48 | 0.090 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 39 | 0.090 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 10 | 0.090 |
Why?
| | Granuloma, Pyogenic | 2 | 2001 | 9 | 0.090 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1733 | 0.090 |
Why?
| | Aged | 13 | 2012 | 23794 | 0.090 |
Why?
| | Professional Competence | 1 | 2011 | 100 | 0.090 |
Why?
| | Medical History Taking | 1 | 1991 | 117 | 0.080 |
Why?
| | Problem-Based Learning | 1 | 2011 | 91 | 0.080 |
Why?
| | DNA, Viral | 5 | 2004 | 363 | 0.080 |
Why?
| | Organizational Innovation | 1 | 2011 | 138 | 0.080 |
Why?
| | Polyvinyls | 2 | 2007 | 21 | 0.080 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 11 | 0.080 |
Why?
| | Quality of Life | 2 | 2013 | 2878 | 0.080 |
Why?
| | Faculty | 1 | 2011 | 146 | 0.080 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.080 |
Why?
| | HIV-1 | 1 | 1996 | 863 | 0.080 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.080 |
Why?
| | Choice Behavior | 1 | 2011 | 170 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 446 | 0.080 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.080 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.080 |
Why?
| | Dental Clinics | 2 | 2001 | 6 | 0.080 |
Why?
| | Parents | 2 | 2016 | 1340 | 0.080 |
Why?
| | Program Development | 1 | 2011 | 364 | 0.080 |
Why?
| | Gels | 3 | 2014 | 80 | 0.080 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.080 |
Why?
| | Cell Division | 3 | 2000 | 792 | 0.080 |
Why?
| | Water Supply | 1 | 1989 | 78 | 0.070 |
Why?
| | Infant, Newborn | 7 | 2002 | 6033 | 0.070 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 53 | 0.070 |
Why?
| | Follow-Up Studies | 6 | 2014 | 5106 | 0.070 |
Why?
| | Hamartoma | 1 | 2008 | 22 | 0.070 |
Why?
| | Nevus | 1 | 2008 | 26 | 0.070 |
Why?
| | Photomicrography | 2 | 2000 | 7 | 0.070 |
Why?
| | Drug Combinations | 2 | 2001 | 343 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 269 | 0.070 |
Why?
| | Vaccination | 1 | 1996 | 1376 | 0.070 |
Why?
| | Porosity | 3 | 2003 | 99 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 17 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1089 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 6 | 0.070 |
Why?
| | Denture, Overlay | 1 | 2007 | 6 | 0.070 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 30 | 0.070 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 10 | 0.070 |
Why?
| | Denture Bases | 1 | 2006 | 1 | 0.070 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 73 | 0.070 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 2 | 0.070 |
Why?
| | Chromium Alloys | 1 | 2006 | 5 | 0.070 |
Why?
| | Prevalence | 6 | 2001 | 2711 | 0.060 |
Why?
| | Tooth Mobility | 2 | 2006 | 6 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 286 | 0.060 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.060 |
Why?
| | HIV | 3 | 1998 | 234 | 0.060 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.060 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.060 |
Why?
| | Osseointegration | 1 | 2007 | 71 | 0.060 |
Why?
| | Root Canal Therapy | 1 | 2006 | 6 | 0.060 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.060 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 24 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2011 | 761 | 0.060 |
Why?
| | Prospective Studies | 6 | 2014 | 7572 | 0.060 |
Why?
| | Silicon | 1 | 2005 | 16 | 0.060 |
Why?
| | Glass | 1 | 2005 | 45 | 0.060 |
Why?
| | Implants, Experimental | 1 | 2005 | 21 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 18 | 0.060 |
Why?
| | Education, Dental | 1 | 2006 | 31 | 0.060 |
Why?
| | Antigens, CD | 2 | 2002 | 521 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 5 | 0.060 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1371 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1022 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 4 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 6 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 136 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 7 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 53 | 0.060 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 182 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2017 | 3540 | 0.060 |
Why?
| | Romania | 2 | 2003 | 12 | 0.060 |
Why?
| | Malocclusion | 2 | 2001 | 24 | 0.060 |
Why?
| | Dental Cementum | 2 | 1995 | 5 | 0.060 |
Why?
| | Dental Pulp Necrosis | 2 | 2001 | 2 | 0.060 |
Why?
| | Treatment Outcome | 6 | 2007 | 10744 | 0.060 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 93 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2004 | 33 | 0.060 |
Why?
| | Phosphoric Acids | 4 | 2001 | 17 | 0.060 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 56 | 0.060 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 47 | 0.060 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 10 | 0.060 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.060 |
Why?
| | Osteosarcoma | 2 | 1998 | 74 | 0.060 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.050 |
Why?
| | Mental Recall | 1 | 1986 | 200 | 0.050 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Lymphocytes | 2 | 2004 | 393 | 0.050 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 507 | 0.050 |
Why?
| | Memory | 1 | 1986 | 248 | 0.050 |
Why?
| | Retrospective Studies | 8 | 2017 | 15504 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 93 | 0.050 |
Why?
| | History, 20th Century | 1 | 2005 | 324 | 0.050 |
Why?
| | Acetates | 2 | 2001 | 99 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 752 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2002 | 303 | 0.050 |
Why?
| | Connexins | 1 | 2003 | 48 | 0.050 |
Why?
| | Sex Distribution | 2 | 2002 | 373 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 106 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 29 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 16 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 356 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 3 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 66 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 116 | 0.050 |
Why?
| | Reed-Sternberg Cells | 1 | 2002 | 3 | 0.050 |
Why?
| | Factor XIIa | 1 | 2002 | 2 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 200 | 0.050 |
Why?
| | Tooth Injuries | 2 | 2018 | 4 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 1097 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 13 | 0.050 |
Why?
| | S100 Proteins | 1 | 2002 | 37 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 116 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 1059 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 592 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 61 | 0.050 |
Why?
| | Lymphoma, Follicular | 1 | 2002 | 40 | 0.050 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.050 |
Why?
| | Remission Induction | 1 | 2003 | 288 | 0.050 |
Why?
| | Decision Trees | 1 | 2002 | 93 | 0.050 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1231 | 0.050 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 17 | 0.050 |
Why?
| | Sclerosis | 1 | 2001 | 13 | 0.050 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.050 |
Why?
| | Skin Diseases | 1 | 2003 | 149 | 0.050 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 16 | 0.050 |
Why?
| | Lactic Acid | 2 | 2014 | 305 | 0.050 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.050 |
Why?
| | Heart | 1 | 1985 | 653 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2002 | 131 | 0.050 |
Why?
| | Caustics | 1 | 2001 | 7 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2003 | 337 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 310 | 0.050 |
Why?
| | 2-Propanol | 1 | 2001 | 20 | 0.050 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 4 | 0.050 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 7 | 0.050 |
Why?
| | Carcinoma, Verrucous | 1 | 2001 | 3 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2005 | 425 | 0.050 |
Why?
| | Dental High-Speed Equipment | 1 | 2001 | 1 | 0.040 |
Why?
| | Facial Neoplasms | 1 | 2001 | 19 | 0.040 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 40 | 0.040 |
Why?
| | alpha 1-Antitrypsin | 1 | 2002 | 108 | 0.040 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 2 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 103 | 0.040 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 24 | 0.040 |
Why?
| | Diet | 1 | 1989 | 1274 | 0.040 |
Why?
| | Plasminogen | 1 | 2001 | 30 | 0.040 |
Why?
| | Melanocytes | 1 | 2001 | 65 | 0.040 |
Why?
| | Mandibular Nerve | 1 | 2000 | 5 | 0.040 |
Why?
| | Time Factors | 8 | 2014 | 6806 | 0.040 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.040 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1320 | 0.040 |
Why?
| | Liability, Legal | 1 | 2001 | 44 | 0.040 |
Why?
| | Silicates | 1 | 2000 | 15 | 0.040 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 2 | 0.040 |
Why?
| | Hodgkin Disease | 1 | 2002 | 138 | 0.040 |
Why?
| | Nickel | 2 | 2006 | 62 | 0.040 |
Why?
| | Alcohol Drinking | 4 | 2012 | 820 | 0.040 |
Why?
| | Phenols | 1 | 2001 | 97 | 0.040 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 56 | 0.040 |
Why?
| | Habits | 1 | 2000 | 49 | 0.040 |
Why?
| | Emergencies | 1 | 2001 | 164 | 0.040 |
Why?
| | Periodontitis | 1 | 2001 | 52 | 0.040 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 62 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 116 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 111 | 0.040 |
Why?
| | Carcinoma, Basal Cell | 1 | 2001 | 74 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 11 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 26 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 87 | 0.040 |
Why?
| | Hair | 1 | 2000 | 84 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 10 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 157 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 164 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 389 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 73 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1620 | 0.040 |
Why?
| | Polymers | 2 | 2000 | 488 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 6 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 327 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 1962 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1773 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 104 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 434 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 620 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 85 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 435 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 25 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 22 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 18 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 29 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 182 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 1982 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 809 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 34 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Suction | 1 | 1998 | 34 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 180 | 0.040 |
Why?
| | Virus Shedding | 1 | 1998 | 48 | 0.040 |
Why?
| | Equipment Design | 1 | 2000 | 521 | 0.040 |
Why?
| | Bone Cysts | 1 | 1998 | 9 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 769 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 269 | 0.040 |
Why?
| | Fibrosarcoma | 1 | 1998 | 22 | 0.040 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.040 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.040 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 46 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1999 | 200 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 313 | 0.030 |
Why?
| | Nose | 1 | 1998 | 67 | 0.030 |
Why?
| | Motor Skills | 1 | 1998 | 97 | 0.030 |
Why?
| | Incidence | 2 | 2012 | 2792 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 675 | 0.030 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 63 | 0.030 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 120 | 0.030 |
Why?
| | Cytokines | 1 | 2005 | 2083 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 556 | 0.030 |
Why?
| | Survival Analysis | 1 | 2000 | 1321 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 316 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.030 |
Why?
| | Radiotherapy | 1 | 1998 | 201 | 0.030 |
Why?
| | Cryptococcosis | 1 | 1997 | 27 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2892 | 0.030 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Role | 1 | 1996 | 31 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 775 | 0.030 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 417 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 27 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 14 | 0.030 |
Why?
| | United States | 5 | 2012 | 14691 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 147 | 0.030 |
Why?
| | Viral Proteins | 3 | 2004 | 340 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 21 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 701 | 0.030 |
Why?
| | Tooth Extraction | 2 | 2001 | 25 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 839 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 1 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 115 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1710 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 199 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 780 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 49 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 171 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 88 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 80 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 14 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 547 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1692 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 626 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 195 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 4 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 3 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 16 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 7585 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 6 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 33 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 12 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 8 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2136 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 7 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 47 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 88 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 57 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 56 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 26 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 20 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 69 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 4 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 14 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 130 | 0.030 |
Why?
| | Awareness | 1 | 2014 | 102 | 0.030 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.030 |
Why?
| | Zidovudine | 1 | 1993 | 78 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2014 | 91 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 1995 | 340 | 0.020 |
Why?
| | Tooth Loss | 1 | 1993 | 27 | 0.020 |
Why?
| | Tolonium Chloride | 1 | 2012 | 3 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 4 | 0.020 |
Why?
| | Bacteria | 1 | 1998 | 854 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 89 | 0.020 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 122 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 25 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 11 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 11 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 28 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 528 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 1981 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 240 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 319 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 96 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 654 | 0.020 |
Why?
| | Bias | 1 | 2011 | 218 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 466 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 74 | 0.020 |
Why?
| | Animals | 5 | 2005 | 36823 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 2 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 717 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2052 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1914 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 132 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 3 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 753 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 432 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 219 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 54 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 696 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5423 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.020 |
Why?
| | Endodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.020 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.020 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.020 |
Why?
| | Periodontics | 1 | 2006 | 7 | 0.020 |
Why?
| | Suppositories | 1 | 1986 | 2 | 0.020 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 2 | 0.020 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 317 | 0.020 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 18 | 0.020 |
Why?
| | Flow Cytometry | 3 | 1995 | 1177 | 0.020 |
Why?
| | Anesthesia, Local | 1 | 1986 | 19 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 5701 | 0.020 |
Why?
| | Amnesia | 1 | 1986 | 43 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1682 | 0.020 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 179 | 0.020 |
Why?
| | Beryllium | 1 | 2006 | 153 | 0.010 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2489 | 0.010 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 6 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 127 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2005 | 330 | 0.010 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 6 | 0.010 |
Why?
| | Lighting | 1 | 2004 | 26 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 28 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 1034 | 0.010 |
Why?
| | Wettability | 1 | 2004 | 15 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2004 | 36 | 0.010 |
Why?
| | In Situ Hybridization | 2 | 1996 | 316 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 83 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 2104 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 4190 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 792 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 67 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1571 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 263 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 8 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 7 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 342 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 13 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 87 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 6 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 12 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 149 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 87 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 344 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 323 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 2282 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 14 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2831 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 95 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 341 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2829 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4518 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 14 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 9 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 965 | 0.010 |
Why?
| | Color | 1 | 2002 | 77 | 0.010 |
Why?
| | Tooth, Supernumerary | 1 | 2001 | 1 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 52 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 13 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 133 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 13 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 846 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Periapical Abscess | 1 | 2001 | 3 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 233 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 558 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 5 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 17 | 0.010 |
Why?
| | Washington | 1 | 2001 | 154 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 5 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 30 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 148 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1065 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 1110 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 514 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 183 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 10 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 15 | 0.010 |
Why?
| | Mice | 3 | 2004 | 17733 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 398 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 180 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 215 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 18 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 152 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 898 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 6 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 10 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 5 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 184 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 126 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 220 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 257 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 2067 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 235 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 71 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 32 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 353 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1455 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 283 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 124 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 752 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 38 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 3 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 23 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 953 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 530 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1544 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 114 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 489 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 97 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 357 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 514 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 106 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2605 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 902 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 105 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 2 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 39 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 116 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1689 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 57 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1501 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 89 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 17 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 31 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 5735 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 4 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 247 | 0.010 |
Why?
| | Gold | 1 | 1994 | 117 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2834 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 73 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 136 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2179 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1396 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 329 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 601 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 379 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1114 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 6728 | 0.000 |
Why?
| | Saccharin | 1 | 1988 | 6 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4281 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 40 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 67 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 5742 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1458 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 167 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 110 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1236 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2667 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 215 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1798 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|